Countries Europe
Aptamer Group Extends Partnership with Unilever to Advance Novel Deodorant Active Ingredients
Aptamer is working with Unilever to develop Optimer binders as novel active ingredients in deodorants that target the enzyme that causes sweat to smell, ai...
September 04, 2024 | News
Biocon Biologics Secures Market Access for Bmab 1200 in Europe, UK, Canada, and Japan Through Janssen Settlement
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...
August 29, 2024 | News
Alzheimer's Association Applauds U.K.'s Approval of Leqembi® Amidst Concerns Over NHS Access Denial
The Alzheimer's Association welcomes decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqem...
August 23, 2024 | News
Finnish Biotech NADMED Secures €3.5M to Transform Vitamin B3 Testing with Groundbreaking NAD Measurement Technology
Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...
August 23, 2024 | News
AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
Pierre Fabre Laboratories Receives Positive CHMP Opinion for BRAFTOVI® + MEKTOVI® in Advanced NSCLC Treatment
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval ...
July 29, 2024 | News
Sugemalimab Becomes First Anti-PD-L1 mAb Approved in Europe for First-Line Treatment of NSCLC
Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved in Europe for first-line treatment of both squamous and non...
July 29, 2024 | News
CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...
July 17, 2024 | News
Accelerated Biosciences and Pluristyx Achieve Breakthrough in Creating Clinical Grade iPSC Lines Using Novel hTSC Starting Material
Accelerated Biosciences ("Accelerated Bio"), in partnership with Pluristyx, proudly announces the successful creation of clinical grade induced pluripotent...
July 15, 2024 | News
Aptamer Group and AstraZeneca Collaborate to Advance Targeted siRNA Delivery for Fibrotic Liver Cells
Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...
July 05, 2024 | News
Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria
Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...
July 04, 2024 | News
Celonic Group Expands Biologics Process Development with New Basel Facility
The Celonic Group, a “Pure Play” Biologics Contract Development Organization (CDMO) expands process development and optimization services in ...
June 19, 2024 | News
SciRhom GmbH Secures Approval for Clinical Trial Application of SR-878 in Austria
SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced the approval of a clinical trial a...
June 14, 2024 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
